Rehovot, Israel
April 2nd, 2021

Evogene Ltd. (NASDAQ, TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (the “SEC”).

The annual report, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC website at http://www.sec.gov/ as well as via the Company’s website at http://www.evogene.com/investor-relations. The Company will deliver a hard copy of its annual report, including its complete audited consolidated financial statements, free of charge, to its shareholders upon request to the Company Media Contact: ir@evogene.com.

Website: http://www.evogene.com

Published: April 5, 2021